The chief of the forensic laboratory at the Public Attorney’s Office (PAO) has made inaccurate claims about a 2014 clinical study on the Dengvaxia vaccine as local health authorities call for a review of the evidence on inoculations against dengue fever.
The Philippines is facing a dengue surge, logging a total of 82,597 cases as of July 16 this year, according to the latest data from the Department of Health (DOH).
In a July 14 interview with broadcaster Noli De Castro on ABS-CBN’s TeleRadyo, Dr. Erwin Erfe, PAO’s forensic laboratory division head, claimed that the proposition to revisit the studies on Dengvaxia is “dangerous.”
Citing a 2014 study on the clinical efficacy and safety of the vaccine, Erfe said:
“Clinical trial po ito. More than 10,000 pong mga kabataan ang sinaksakan dito. Napakababa po ng efficacy, 56% lang. At six out of 10 na sasaksakan mo ng Dengvaxia ay magsa-suffer ng severe adverse effects, anim out of 10.”
(This was a clinical trial. More than 10,000 children were vaccinated. The efficacy was very low, just 56%. Six out of 10 who were vaccinated with Dengvaxia will suffer severe adverse effects, six out of 10.)
Source: TeleRadyo, PAO binatikos ang panawagang gamitin ulit ang Dengvaxia sa kabila ng rising dengue cases, watch from 5:06 – 5:28
Then, he added:
“Kasama po dito ‘yung deaths. ‘Yun nga po ‘yung apat na nakamamatay na sinabi ng Sanofi, dinisclose po sa FDA (Food and Drug Administration) na itinago naman po ng Department of...
A waste disposal company won dismissal of a False Claims Act suit alleging it improperly billed the federal and Montana governments for services it didn’t provide. Whistleblowers Max Bauer Jr. and...